Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Kopin
KOPN
$756M
| $142K | ﹤0.01% |
35,606
-14,561
| -29% | -$52.8K |
|
5227
CALL
New York Times
NYT
$10.5B
| $142K | ﹤0.01% |
11,800
-21,000
| -64% | -$249K |
|
5228
PUT
Cincinnati Financial
CINF
$27.5B
| $141K | ﹤0.01% |
3,000
-100
| -3% | -$4.77K |
|
5229
CALL
State Street SPDR S&P Bank ETF
KBE
$1.66B
| $141K | ﹤0.01% |
4,700
-500
| -10% | -$15.3K |
|
|
MGF
5230
Aberdeen Government Markets Income Fund
MGF
$92.6M
| $141K | ﹤0.01% |
28,240
+11,915
| +73% | +$68.1K |
|
5231
MACOM Technology Solutions
MTSI
$23B
| $141K | ﹤0.01% |
8,261
+2,748
| +50% | +$43.6K |
|
|
GFY
5232
DELISTED
Western Asset Variable Rate Strategic Fund, Inc
GFY
| $141K | ﹤0.01% |
8,308
+2,556
| +44% | +$43.1K |
|
|
ALR
5233
PUT
DELISTED
Alere Inc
ALR
| $141K | ﹤0.01% |
4,700
-1,500
| -24% | -$45.7K |
|
|
CBEY
5234
DELISTED
CBEYOND INC COM STK
CBEY
| $141K | ﹤0.01% |
23,451
-3,027
| -11% | -$21.9K |
|
|
MKTG
5235
DELISTED
RESPONSYS INC COM STK (CA)
MKTG
| $141K | ﹤0.01% |
8,831
-3,503
| -28% | -$51.7K |
|
5236
eGain
EGAN
$202M
| $140K | ﹤0.01% |
9,303
+7,523
| +423% | +$89.8K |
|
5237
CALL
Gold Fields
GFI
$33.4B
| $140K | ﹤0.01% |
34,900
-31,200
| -47% | -$167K |
|
5238
CALL
MKS Inc
MKSI
$19.7B
| $140K | ﹤0.01% |
5,400
+4,700
| +671% | +$125K |
|
5239
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $140K | ﹤0.01% |
4,500
+1,400
| +45% | +$44.3K |
|
5240
Verastem
VSTM
$519M
| $140K | ﹤0.01% |
971
+908
| +1,441% | +$159K |
|
|
NATI
5241
DELISTED
National Instruments Corp
NATI
| $140K | ﹤0.01% |
4,670
-2,135
| -31% | -$62.1K |
|
|
CSH
5242
CALL
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $140K | ﹤0.01% |
6,832
+1,983
| +41% | +$39.5K |
|
5243
CALL
ON Semiconductor
ON
$18.6B
| $139K | ﹤0.01% |
19,800
-7,200
| -27% | -$55.2K |
|
5244
CALL
Penske Automotive Group
PAG
$14.2B
| $139K | ﹤0.01% |
3,300
-3,600
| -52% | -$138K |
|
|
5245
PUT
Penske Automotive Group
PAG
$14.2B
| $139K | ﹤0.01% |
3,300
-2,200
| -40% | -$84.2K |
|
5246
PUT
Reliance Steel & Aluminium
RS
$21.3B
| $139K | ﹤0.01% |
1,900
+1,000
| +111% | +$69.8K |
|
|
AJRD
5247
PUT
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $139K | ﹤0.01% |
8,700
-14,200
| -62% | -$233K |
|
|
ECYT
5248
PUT
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $139K | ﹤0.01% |
+10,700
| New | +$169K |
|
|
ACCL
5249
DELISTED
Accelrys Inc
ACCL
| $139K | ﹤0.01% |
15,442
+11,811
| +325% | +$108K |
|
|
EXAS
5250
DELISTED
Exact Sciences
EXAS
| $138K | ﹤0.01% |
12,472
+1,918
| +18% | +$24.6K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.